GLORIA MARGISON: Open Payments
NPI 1134231285 · EAST BERNSTADT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,176 in 116 payments from 22 companies in 2025. Trend: 2023 $2,170 · 2024 $2,333 · 2025 $2,176
Food & beverage: $2,171Education: $4
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $441 |
| Lilly USA, LLC | 18 | $348 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $213 |
| Corcept Therapeutics | 12 | $160 |
| Novo Nordisk Inc | 11 | $143 |
| Verona Pharma, Inc. | 7 | $138 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 6 | $65 |
Products named: FARXIGA, MOUNJARO, Kerendia, Korlym, Ohtuvayre, ZEPBOUND, TRELEGY ELLIPTA, TEZSPIRE.
Industry payments across KY — which companies pay providers there.
